Institutions: University of Birmingham, University Hospitals Birmingham NHS Foundation Trust Research Paper: The potential of PIVKA-II as a treatment response biomarker in hepatocellular carcinoma: a prospective United Kingdom cohort study The mechanism of these effects on neoplastic epithelial cells is poorly understood.” Quote: “CCL20-CCR6 interactions promote colorectal cancer through direct effects on neoplastic epithelial cells and through modulating the tumor microenvironment. Institutions: VA Boston Healthcare System, Harvard Medical School, Beth Israel Deaconess Medical Center, Dana-Farber Cancer Institute, Brigham and Women’s Hospital Retrieved 19 April 2016.Oncotarget’s Volume 12, Issue 24 New Publications Listen to an audio version of this post Cover (Research Paper): CCL20 induces colorectal cancer neoplastic epithelial cell proliferation, migration, and further CCL20 production through autocrine HGF-c-Met and MSP-MSPR signaling pathways Archived from the original on 2 December 2016. "LIST OF STANDALONE JOURNALS: Potential, possible, or probable predatory scholarly open-access journals". "Oncotarget's Peer Review is Highly Questionable (Jeffrey Beall".
Archived from the original on 20 April 2016. "Oncotarget's Peer Review is Highly Questionable". ^ "Indexing company praises cancer journal, then kicks it out".^ "Rising Stars from Essential Science Indicators".^ a b "Indexing company praises cancer journal, then kicks it out".
National Center for Biotechnology Information. Allegedly, journal editor Mikhail Blagosklonny responded by threatening to retract the papers of Beall's colleagues at the University of Colorado. The peer review process employed by the journal has been criticized by Jeffrey Beall, a university librarian and expert on predatory open access publishing, who also included the journal on his list of "potential, possible, or probable predatory scholarly open-access journals" in July 2015. In 2018 Clarivate Analytics, who maintain the most prominent Impact factor index, delisted the journal from the Journal Citation Reports and all of its other products because "the journal no longer meets the standards necessary for continued coverage", despite having listed the journal as a "Rising Star from Essential Science Indicators" only a few months prior. In 2017, the journal was dropped from MEDLINE. It was dropped from Index Medicus/ MEDLINE in 2017 and in 2018 from BIOSIS Previews and the Science Citation Index Expanded. The journal is abstracted and indexed in PubMed, Meta, and Scopus.
0 kommentar(er)
